Patents for A61P 33 - Antiparasitic agents (21,787)
05/1998
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0643690B1 Desferrioxamine-b salts and their use as orally effective iron chelators
05/20/1998EP0463053B1 Production and use of anthelmintic agents and protective immunogens
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753235 Recombinant canine herpesviruses
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020161A1 Methods for identifying genes essential to the growth of an organism
05/14/1998WO1998020142A1 Notch
05/14/1998DE19640817A1 Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1 A recombinant preparation process for a complete malaria antigen gp190 / MSP 1
05/14/1998CA2270153A1 Methods for identifying genes essential to the growth of an organism
05/13/1998EP0841392A2 Attenuated live neospora vaccine
05/12/1998US5750695 Antiparasitic paraherquamides
05/12/1998US5750573 Guanylhydrazones and their use to treat inflammatory conditions
05/12/1998US5750533 Plants, animals
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/12/1998CA2001568C Medicament for treating toxoplasmosis
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018462A1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270138A1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/06/1998EP0710242B1 Antiparasitic agents
05/05/1998US5747473 L-nucleoside analogues and pharmaceutical compositions
05/05/1998US5747294 Antibody formed by hybridomas produced using cells from animal immunized with borrelia burgdorferi
04/1998
04/30/1998WO1997048976A3 Method for discovering novel anthelmintic compounds
04/29/1998EP0838522A2 Coccidiosis poultry vaccine
04/29/1998EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque
04/29/1998EP0557348B1 Avermectins and milbemycins to treat parasitic in dogs
04/28/1998US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
04/28/1998US5744494 Veterinary, human use
04/23/1998WO1998016515A1 Compounds and methods to treat infectious diseases
04/23/1998WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof
04/23/1998WO1998016184A2 Purine l-nucleosides, analogs and uses thereof
04/23/1998WO1998016107A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites
04/23/1998CA2267978A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites
04/23/1998CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof
04/23/1998CA2266889A1 Purine l-nucleosides, analogs and uses thereof
04/22/1998EP0836481A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
04/22/1998CN1179715A Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
04/21/1998CA1339828C Protective synthetic peptide against malaria and encoding gene
04/16/1998WO1998015624A1 Galectin 8, 9, 10 and 10sv
04/16/1998WO1998015287A1 Vaccines
04/16/1998CA2268022A1 Galectin 8, 9, 10 and 10sv
04/16/1998CA2267191A1 Vaccines
04/15/1998EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex
04/15/1998EP0835266A1 Modified/chimeric superantigens and their use
04/15/1998EP0835258A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
04/14/1998US5739170 Inhibitors of metazoan parasite proteases
04/14/1998US5739167 Desferrioxamine-B salts and their use as orally effective iron chelators
04/14/1998US5739141 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
04/09/1998WO1998014583A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1
04/09/1998WO1998014212A1 Method of producing active immunity with vaccine conjugate
04/09/1998WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease
04/09/1998WO1998001546A3 Polyketides and their synthesis
04/09/1998CA2267421A1 Oral administration of chicken yolk antibodies to treat disease
04/08/1998EP0833917A2 Malarial pre-erythrocytic stage polypeptide molecules
04/07/1998US5736557 N,N-bis (quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials
04/01/1998EP0832118A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
04/01/1998EP0832112A1 Monocyte chemotactic protein-4
04/01/1998EP0832099A1 Reversible cysteine protease inhibitors
04/01/1998EP0831897A1 In ovo vaccination against coccidiosis
04/01/1998EP0831896A1 In ovo vaccination against coccidiosis
04/01/1998EP0831806A1 Multidentate metal complexes and methods of making and using thereof
04/01/1998EP0831704A1 Use of oxazolines for combatting ectoparasites
04/01/1998EP0677054B1 New antiparasitic agents related to the milbemycins and avermectins
04/01/1998CN1177597A Polyene antibiotics 3874 H1-H6, preparation method and use thereof
03/1998
03/31/1998US5734035 Nematode vaccine
03/31/1998US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
03/31/1998US5733887 Related to avermectins and milbemycins
03/31/1998US5733778 Vaccines, medical diagnosis
03/31/1998US5733772 Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733544 Nematicidal bacillus strain and metabolite and methods of use thereof
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012196A1 Nodulisporic acid derivatives
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011780A1 Novel parasiticide combination
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/25/1998EP0830135A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
03/25/1998EP0830134A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders
03/24/1998US5731008 Electrically hydrolyzed salines as microbicides
03/24/1998US5730984 Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010749A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2264646A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/18/1998EP0829540A1 Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor
03/18/1998EP0829487A2 Polyene antibiotics 3874 H1 to H6, method for their preparation and use
03/18/1998EP0829486A2 Polyene antibiotics, 3874 H1 to H6, method for their preparation and use
03/18/1998EP0828506A2 Endoparasiticidal agents
03/18/1998EP0828487A1 Agents for use against parasitic protozoa
03/18/1998EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/12/1998WO1998009971A1 25-methylene and 24,25-epoxy marcfortines and paraherquamides
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor